Drugs logo Adis International logo

Publisher: Adis International

Related content
Volume 59, Number 2, February 2000

< previous issue | all issues | next issue >

Articles

Drug-Resistant Tuberculosis: What Do We Do Now?
pp. 171-179(9)
Authors: Telenti A.; Iseman M.

Reviews

Important Drug Interactions in Dermatology
pp. 181-192(12)
Authors: Roos T.C.; Merk H.F.

Articles

Lidocaine Patch 5%
pp. 245-249(5)
Authors: Comer A.M.; Lamb H.M.

Lidocaine Patch 5%: A Viewpoint by Bradley S. Galer
pp. 250-251(2)
Author: Galer B.S.

Lidocaine Patch 5%: A Viewpoint by Andrew P. Baranowski
pp. 250-251(2)
Author: Baranowski A.P.

Insulin Glargine
pp. 253-260(8)
Authors: Gillies P.S.; Figgitt D.P.; Lamb H.M.

Insulin Glargine: A Viewpoint by Matthew C. Riddle
pp. 261-262(2)
Author: Riddle M.C.

Insulin Glargine: A Viewpoint by Philip D. Home
pp. 261-262(2)
Author: Home P.D.

Dexmedetomidine
pp. 263-268(6)
Authors: Bhana N.; Goa K.L.; McClellan K.J.

Dexmedetomidine: A Viewpoint by Dr Pekka Talke
pp. 269-270(2)
Author: Talke P.

Dexmedetomidine: A Viewpoint by Dr Erkan Hassan
pp. 269-270(2)
Author: Hassan E.

Azimilide
pp. 271-277(7)
Authors: Clemett D.; Markham A.

Azimilide: A Viewpoint by Bramah Singh
pp. 278-279(2)
Author: Singh B.

Azimilide: A Viewpoint by Stanley Nattel
pp. 279-278(0)
Author: Nattel S.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page